Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.
Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.
Ion mobility-mass spectrometry (IM-MS) in combination with molecular modelling offers the potential for small molecule structural isomer identification by measurement of their gas phase collision cross sections (CCSs). Successful application of this approach to drug metabolite identification would facilitate resource reduction, including animal usage, and may benefit other areas of pharmaceutical structural characterisation including impurity profiling and degradation chemistry. However, the conformational behaviour of drug molecules and their metabolites in the gas phase is poorly understood. Here the gas phase conformational space of drug and drug-like molecules has been investigated as well as the influence of protonation and adduct formation on the conformations of drug metabolite structural isomers. The use of CCSs, measured from IM-MS and molecular modelling information, for the structural identification of drug metabolites has also been critically assessed. Detection of structural isomers of drug metabolites using IM-MS is demonstrated and, in addition, a molecular modelling approach has been developed offering rapid conformational searching and energy assessment of candidate structures which agree with experimental CCSs. Here it is illustrated that isomers must possess markedly dissimilar CCS values for structural differentiation, the existence and extent of CCS differences being ionization state and molecule dependent. The results present that IM-MS and molecular modelling can inform on the identity of drug metabolites and highlight the limitations of this approach in differentiating structural isomers.
2273–2280
Reading, Eamonn
62fed933-f867-4c72-89e7-83aea573a836
Munoz-Muriedas, Jordi
85b1b025-be57-4ff0-9d9b-96d8e9e296c8
Roberts, Andrew D
32d9e53a-1173-4a62-b074-f7f5a1a32904
Dear, Gordon J
66afac91-7f5f-4519-bac9-dae2c3bd902e
Robinson, Carol V
a23ad585-fdc3-4574-a543-19e9b1782b0a
Beaumont, Claire
a354f995-c7ae-442e-9df2-25b7ef166ec1
11 January 2016
Reading, Eamonn
62fed933-f867-4c72-89e7-83aea573a836
Munoz-Muriedas, Jordi
85b1b025-be57-4ff0-9d9b-96d8e9e296c8
Roberts, Andrew D
32d9e53a-1173-4a62-b074-f7f5a1a32904
Dear, Gordon J
66afac91-7f5f-4519-bac9-dae2c3bd902e
Robinson, Carol V
a23ad585-fdc3-4574-a543-19e9b1782b0a
Beaumont, Claire
a354f995-c7ae-442e-9df2-25b7ef166ec1
Reading, Eamonn, Munoz-Muriedas, Jordi, Roberts, Andrew D, Dear, Gordon J, Robinson, Carol V and Beaumont, Claire
(2016)
Elucidation of drug metabolite structural isomers using molecular modeling coupled with ion mobility mass spectrometry.
Analytical Chemistry, .
(doi:10.1021/acs.analchem.5b04068).
Abstract
Ion mobility-mass spectrometry (IM-MS) in combination with molecular modelling offers the potential for small molecule structural isomer identification by measurement of their gas phase collision cross sections (CCSs). Successful application of this approach to drug metabolite identification would facilitate resource reduction, including animal usage, and may benefit other areas of pharmaceutical structural characterisation including impurity profiling and degradation chemistry. However, the conformational behaviour of drug molecules and their metabolites in the gas phase is poorly understood. Here the gas phase conformational space of drug and drug-like molecules has been investigated as well as the influence of protonation and adduct formation on the conformations of drug metabolite structural isomers. The use of CCSs, measured from IM-MS and molecular modelling information, for the structural identification of drug metabolites has also been critically assessed. Detection of structural isomers of drug metabolites using IM-MS is demonstrated and, in addition, a molecular modelling approach has been developed offering rapid conformational searching and energy assessment of candidate structures which agree with experimental CCSs. Here it is illustrated that isomers must possess markedly dissimilar CCS values for structural differentiation, the existence and extent of CCS differences being ionization state and molecule dependent. The results present that IM-MS and molecular modelling can inform on the identity of drug metabolites and highlight the limitations of this approach in differentiating structural isomers.
This record has no associated files available for download.
More information
Published date: 11 January 2016
Identifiers
Local EPrints ID: 479122
URI: http://eprints.soton.ac.uk/id/eprint/479122
ISSN: 0003-2700
PURE UUID: 79af7611-55cb-4d02-911f-84c3ebb6823b
Catalogue record
Date deposited: 20 Jul 2023 16:36
Last modified: 17 Mar 2024 04:19
Export record
Altmetrics
Contributors
Author:
Eamonn Reading
Author:
Jordi Munoz-Muriedas
Author:
Andrew D Roberts
Author:
Gordon J Dear
Author:
Carol V Robinson
Author:
Claire Beaumont
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics